---
title: "Micro-Caps Chase Overseas Growth as Domestic Markets Stagnate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302535341.md"
description: "Hong Kong micro-caps pursued overseas growth in October, with FDB Holdings securing a $11.8M Kazakhstan power plant contract and Forest Cabin accelerating Hong Kong expansion through share buybacks. CStone Pharma gained UK regulatory approval, while Man Shun Group negotiated potential control change."
datetime: "2026-10-21T09:18:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302535341.md)
  - [en](https://longbridge.com/en/news/302535341.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302535341.md)
generator: "portal-rs"
---

# Micro-Caps Chase Overseas Growth as Domestic Markets Stagnate

Hong Kong micro-caps turned to overseas markets as domestic headwinds intensified. FDB Holdings (1826.HK) surged 17% after securing a $11.8 million EPC contract for a 4.5MW natural gas plant in Kazakhstan—funds partly drawn from rights issue proceeds. Forest Cabin (2657.HK) accelerated Hong Kong expansion with East Point City flagship store opening, backed by four consecutive days of share buybacks totaling HK$31.6 million. CStone Pharma-B (2616.HK) gained UK approval for Sugemalimab, with CEO Yang Jianxin adding 496,000 shares in September. DZUG (1635.HK) committed RMB 214.5 million to environmental fund investments while maintaining AA- ESG rating. Man Shun Group (1746.HK) disclosed ongoing negotiations for potential control transfer under Hong Kong Takeovers Code. Universe Ent (1046.HK) plunged 20.3% following FY2026 revenue collapse of 74.6%. Heng Xinfeng (1920.HK) posted 13.6% revenue growth with new beauty segment contribution. Weili Holdings (2372.HK) saw unexplained 23.9% single-day plunge on October 13. Chunli Medical (1858.HK) prepares Q3 results announcement with Morgan Stanley raising stake to 5%. HYGIEIA GROUP (1650.HK) maintained steady 8% revenue growth in Singapore waste management sector.

### Related Stocks

- [01920.HK](https://longbridge.com/en/quote/01920.HK.md)
- [01826.HK](https://longbridge.com/en/quote/01826.HK.md)
- [02657.HK](https://longbridge.com/en/quote/02657.HK.md)
- [02372.HK](https://longbridge.com/en/quote/02372.HK.md)
- [01746.HK](https://longbridge.com/en/quote/01746.HK.md)
- [01858.HK](https://longbridge.com/en/quote/01858.HK.md)
- [01650.HK](https://longbridge.com/en/quote/01650.HK.md)
- [01635.HK](https://longbridge.com/en/quote/01635.HK.md)
- [02616.HK](https://longbridge.com/en/quote/02616.HK.md)
- [01046.HK](https://longbridge.com/en/quote/01046.HK.md)

## Related News & Research

- [Shanghai Forest Cabin Cosmetics Files HKEX Return Disclosing Share Buyback](https://longbridge.com/en/news/306261775.md)
- [CStone Pharmaceuticals Grants 960,000 Share Options, 640,000 Restricted Share Units to Employees](https://longbridge.com/en/news/306256886.md)
- [Man Shun Extends Takeover Exclusivity Period to Nov. 30](https://longbridge.com/en/news/305644656.md)
- [Shanghai Forest Cabin Cosmetics Files HKEX Return Disclosing Share Buyback](https://longbridge.com/en/news/305150825.md)
- [Man Shun Says Potential Buyer's China Investment Approval Remains Pending](https://longbridge.com/en/news/304990710.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**